Roche inks $83M iPSC pact with Cellular Dynamics

Roche ($RHHBY) has inked a collaboration deal with Madison, WI-based Cellular Dynamics for a supply of induced pluripotent stem cell-derived iCell products that can be used to ID new drug candidates. The deal is worth up to $83 million for CDI. "Our partnerships with established leaders in the pharmaceutical industry, now including Roche, demonstrate that CDI products are increasingly becoming important tools for efficient drug discovery," says CDI CEO Kaz Hirao. "This agreement is the largest single collaboration for CDI to date." Release